1.41
+0.1(+7.63%)
Currency In USD
| Previous Close | 1.31 |
| Open | 1.28 |
| Day High | 1.41 |
| Day Low | 1.27 |
| 52-Week High | 5 |
| 52-Week Low | 1.11 |
| Volume | 1.73M |
| Average Volume | 1.63M |
| Market Cap | 375.24M |
| PE | -1.64 |
| EPS | -0.86 |
| Moving Average 50 Days | 1.64 |
| Moving Average 200 Days | 2.94 |
| Change | 0.1 |
If you invested $1000 in Autolus Therapeutics plc (AUTL) since IPO date, it would be worth $56.4 as of May 01, 2025 at a share price of $1.41. Whereas If you bought $1000 worth of Autolus Therapeutics plc (AUTL) shares 5 years ago, it would be worth $156.67 as of May 01, 2025 at a share price of $1.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)
GlobeNewswire Inc.
Apr 25, 2025 4:06 PM GMT
UK Medicines and Healthcare products Regulatory Agency (MHRA) authorisation based on FELIX clinical trial of obecabtagene autoleucel in adult patients with r/r B-ALL1AUCATZYL® licensed from MHRA under ‘conditional marketing authorisation’, meaning th
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
GlobeNewswire Inc.
Apr 23, 2025 8:05 PM GMT
Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, including acute lymphoblastic leukemia (ALL), lupus nephritis (LN) and multiple sclerosis (MS)Preliminary data in init
Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
GlobeNewswire Inc.
Apr 22, 2025 11:00 AM GMT
LONDON, April 22, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announces that it wi